| Market Cap | 2.53B | P/E | - | EPS this Y | 35.90% | Ern Qtrly Grth | - |
| Income | -221.17M | Forward P/E | -43.75 | EPS next Y | 28.00% | 50D Avg Chg | 9.00% |
| Sales | 1.36B | PEG | -0.61 | EPS past 5Y | - | 200D Avg Chg | -10.00% |
| Dividend | N/A | Price/Book | 2.04 | EPS next 5Y | 20.00% | 52W High Chg | -56.00% |
| Recommedations | 1.90 | Quick Ratio | 0.40 | Shares Outstanding | 648.36M | 52W Low Chg | 60.00% |
| Insider Own | 29.93% | ROA | 0.97% | Shares Float | 588.57M | Beta | 1.50 |
| Inst Own | 2.95% | ROE | -18.96% | Shares Shorted/Prior | -/- | Price | 3.50 |
| Gross Margin | 46.16% | Profit Margin | -18.59% | Avg. Volume | 358,638 | Target Price | 5.67 |
| Oper. Margin | 2.21% | Earnings Date | Nov 7 | Volume | 150,691 | Change | -2.40% |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.